Multiplex Assay Kit for Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay)

OLM4; hGC1; hOLfD; OlfD; GW112; GC1; G-CSF-stimulated clone 1 protein; Antiapoptotic protein GW112

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-90 84
EDTA plasma(n=5) 88-96 92
heparin plasma(n=5) 98-105 102

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 86-94% 84-102% 87-96% 80-90%
EDTA plasma(n=5) 86-98% 78-104% 92-101% 78-96%
heparin plasma(n=5) 89-101% 97-104% 95-104% 97-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:OLFM4) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Molecular & Cellular Proteomics Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers PubMed: PMC3205865
PLoS One Olfactomedin 4 serves as a marker for disease severity in pediatric respiratory syncytial virus (RSV) infection PubMed: 26162090
网页打不开 Olfactomedin-4 serves as a prognostic marker for disease severity in pediatric respiratory syncytial virus infection 10.1.1.930.8821
DSpace Maksa rakuvälise maatriksi komponentide muutuste iseloomustamine maksakahjustuse korral handle:10062
ANNALS OF TRANSLATIONAL MEDICINE Serum levels of olfactomedin 4: a biomarker for asthma control state in asthmatics Pubmed: 32395538
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Notch and TNF-¦Á signaling promote cytoplasmic accumulation of OLFM4 in intestinal epithelium cells and exhibit a cell protective role in the inflamed mucosa?¡­ 33490652
J Inflamm Res OLFM4 Regulates Lung Epithelial Cell Function in Sepsis-Associated ARDS/ALI via LDHA-Mediated NF-κB Signaling 34955649
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA162Mu01 Recombinant Olfactomedin 4 (OLFM4) Positive Control; Immunogen; SDS-PAGE; WB.
RPA162Mu02 Recombinant Olfactomedin 4 (OLFM4) Positive Control; Immunogen; SDS-PAGE; WB.
PAA162Mu01 Polyclonal Antibody to Olfactomedin 4 (OLFM4) WB; IHC; ICC; IP.
PAA162Mu02 Polyclonal Antibody to Olfactomedin 4 (OLFM4) WB; IHC; ICC; IP.
LAA162Mu71 Biotin-Linked Polyclonal Antibody to Olfactomedin 4 (OLFM4) WB; IHC; ICC.
LAA162Mu81 FITC-Linked Polyclonal Antibody to Olfactomedin 4 (OLFM4) WB; IHC; ICC; IF.
SEA162Mu ELISA Kit for Olfactomedin 4 (OLFM4) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA162Mu Multiplex Assay Kit for Olfactomedin 4 (OLFM4) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.